chr16-1202152-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.1702G>A​(p.Asp568Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,550,318 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D568V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0011 ( 19 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 1.30

Publications

8 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00608176).
BP6
Variant 16-1202152-G-A is Benign according to our data. Variant chr16-1202152-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00101 (154/152366) while in subpopulation SAS AF = 0.00455 (22/4832). AF 95% confidence interval is 0.00308. There are 1 homozygotes in GnomAd4. There are 78 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 154 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1663G>A p.Asp555Asn missense_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1663G>A p.Asp555Asn missense_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1702G>A p.Asp568Asn missense_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*1149G>A non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1702G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*1149G>A 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+317G>A intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.000998
AC:
152
AN:
152248
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00194
AC:
283
AN:
146046
AF XY:
0.00227
show subpopulations
Gnomad AFR exome
AF:
0.000149
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.0143
Gnomad EAS exome
AF:
0.0000929
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00111
Gnomad OTH exome
AF:
0.00211
GnomAD4 exome
AF:
0.00113
AC:
1574
AN:
1397952
Hom.:
19
Cov.:
36
AF XY:
0.00126
AC XY:
867
AN XY:
689642
show subpopulations
African (AFR)
AF:
0.000475
AC:
15
AN:
31590
American (AMR)
AF:
0.00139
AC:
50
AN:
35848
Ashkenazi Jewish (ASJ)
AF:
0.0145
AC:
366
AN:
25190
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35748
South Asian (SAS)
AF:
0.00298
AC:
236
AN:
79302
European-Finnish (FIN)
AF:
0.0000212
AC:
1
AN:
47262
Middle Eastern (MID)
AF:
0.0121
AC:
69
AN:
5692
European-Non Finnish (NFE)
AF:
0.000646
AC:
697
AN:
1079342
Other (OTH)
AF:
0.00240
AC:
139
AN:
57978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
100
200
301
401
501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00101
AC:
154
AN:
152366
Hom.:
1
Cov.:
34
AF XY:
0.00105
AC XY:
78
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41590
American (AMR)
AF:
0.000849
AC:
13
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
45
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00455
AC:
22
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68030
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00218
Hom.:
1
Bravo
AF:
0.00114
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000593
AC:
4
ExAC
AF:
0.00103
AC:
102
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS2 -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, childhood absence, susceptibility to, 6 Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
16
DANN
Benign
0.85
DEOGEN2
Benign
0.12
T;.;.;.
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.85
D;D;D;.
MetaRNN
Benign
0.0061
T;T;T;T
MetaSVM
Uncertain
-0.094
T
MutationAssessor
Benign
1.0
L;.;L;L
PhyloP100
1.3
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.30
N;.;N;N
REVEL
Benign
0.15
Sift
Benign
0.44
T;.;T;T
Sift4G
Benign
0.49
T;.;T;T
Polyphen
0.0040
B;.;B;B
Vest4
0.27
MVP
0.63
ClinPred
0.0021
T
GERP RS
2.9
Varity_R
0.063
gMVP
0.39
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61056448; hg19: chr16-1252152; COSMIC: COSV62005400; COSMIC: COSV62005400; API